Nutex Health Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Nutex Health amended its Payment Dispute Resolution Services Agreement with HaloMD, effective June 30, 2026. Key changes: (1) Service fee rate held steady at 16% of net settlement/arbitration amounts for claims with award determinations on/after July 1, 2026; (2) Term extended through December 31, 2029 with automatic annual renewals; (3) Nutex granted right to perform dispute resolution in-house or via third-party at up to four facility locations (one existing plus one per year for 2027–2029); (4) HaloMD gains payment verification rights and ability to withdraw delinquent fees from Nutex's operating account after three missed payments; (5) Specific carve-outs for HaloMD's prohibited services and proprietary work-product protections clarified.
Why this rating
Amendment extends key vendor relationship and clarifies dispute-resolution economics. 16% rate unchanged; limited operational impact. No major financial or strategic shift evident relative to $524M market cap.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.